Filtered By:
Source: American Journal of Translational Research
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 412 results found since Jan 2013.
ETS-1/c-Met drives resistance to sorafenib in hepatocellular carcinoma
CONCLUSION: c-Met overexpression and activation is an essential mechanism of sorafenib resistance in HCC. Combination therapy of sorafenib plus c-Met inhibitor overcame the resistance of sorafenib-targeted therapy for HCC.PMID:36915773 | PMC:PMC10006745
Source: American Journal of Translational Research - March 14, 2023 Category: Research Authors: Yongfang Ma Xueke Liu Xiaolong Tang Source Type: research
